These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33467709)

  • 1. Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer's Disease Agents.
    Poliseno V; Chaves S; Brunetti L; Loiodice F; Carrieri A; Laghezza A; Tortorella P; Magalhães JD; Cardoso SM; Santos MA; Piemontese L
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33467709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donepezil-based hybrids as multifunctional anti-Alzheimer's disease chelating agents: Effect of positional isomerization.
    Costa M; Josselin R; Silva DF; Cardoso SM; May NV; Chaves S; Santos MA
    J Inorg Biochem; 2020 May; 206():111039. PubMed ID: 32171933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis, and In Vitro Evaluation of Hydroxybenzimidazole-Donepezil Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease.
    Chaves S; Resta S; Rinaldo F; Costa M; Josselin R; Gwizdala K; Piemontese L; Capriati V; Pereira-Santos AR; Cardoso SM; Santos MA
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32098407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's drug candidates.
    Piemontese L; Tomás D; Hiremathad A; Capriati V; Candeias E; Cardoso SM; Chaves S; Santos MA
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1212-1224. PubMed ID: 30160188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitors.
    Gabr MT; Abdel-Raziq MS
    Bioorg Chem; 2018 Oct; 80():245-252. PubMed ID: 29966870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Claulansine F-Donepezil Hybrids as Anti-Alzheimer's Disease Agents with Cholinergic, Free-Radical Scavenging, and Neuroprotective Activities.
    Zang Y; Liu K; Wang W; Li C; Ma J; Yang J; Chen X; Wang X; Zhang D
    Molecules; 2021 Feb; 26(5):. PubMed ID: 33671020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromone-lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities.
    Jalili-Baleh L; Nadri H; Forootanfar H; Küçükkılınç TT; Ayazgök B; Sharifzadeh M; Rahimifard M; Baeeri M; Abdollahi M; Foroumadi A; Khoobi M
    Daru; 2021 Jun; 29(1):23-38. PubMed ID: 33420969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties.
    Cai P; Fang SQ; Yang HL; Yang XL; Liu QH; Kong LY; Wang XB
    Eur J Med Chem; 2018 Sep; 157():161-176. PubMed ID: 30096650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease.
    Korabecny J; Spilovska K; Mezeiova E; Benek O; Juza R; Kaping D; Soukup O
    Curr Med Chem; 2019; 26(30):5625-5648. PubMed ID: 29768996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer's disease.
    Sang Z; Wang K; Shi J; Liu W; Cheng X; Zhu G; Wang Y; Zhao Y; Qiao Z; Wu A; Tan Z
    Eur J Med Chem; 2020 Apr; 192():112180. PubMed ID: 32131034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Turning Donepezil into a Multi-Target-Directed Ligand through a Merging Strategy.
    Perone R; Albertini C; Uliassi E; Di Pietri F; de Sena Murteira Pinheiro P; Petralla S; Rizzardi N; Fato R; Pulkrabkova L; Soukup O; Tramarin A; Bartolini M; Bolognesi ML
    ChemMedChem; 2021 Jan; 16(1):187-198. PubMed ID: 32716144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
    Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
    Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease.
    Brunetti L; Leuci R; Carrieri A; Catto M; Occhineri S; Vinci G; Gambacorta L; Baltrukevich H; Chaves S; Laghezza A; Altomare CD; Tortorella P; Santos MA; Loiodice F; Piemontese L
    Eur J Med Chem; 2022 Jul; 237():114358. PubMed ID: 35462163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, in vitro and in vivo evaluation of novel pyrrolizine-based compounds with potential activity as cholinesterase inhibitors and anti-Alzheimer's agents.
    El-Sayed NA; Farag AE; Ezzat MAF; Akincioglu H; Gülçin İ; Abou-Seri SM
    Bioorg Chem; 2019 Dec; 93():103312. PubMed ID: 31586715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with β-amyloid anti-aggregation properties and beneficial effects on memory in vivo.
    Więckowska A; Więckowski K; Bajda M; Brus B; Sałat K; Czerwińska P; Gobec S; Filipek B; Malawska B
    Bioorg Med Chem; 2015 May; 23(10):2445-57. PubMed ID: 25868744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Flavone-Cyanoacetamide Hybrids with a Combination of Cholinergic, Antioxidant, Modulation of β-Amyloid Aggregation, and Neuroprotection Properties as Innovative Multifunctional Therapeutic Candidates for Alzheimer's Disease and Unraveling Their Mechanism of Action with Acetylcholinesterase.
    Basha SJ; Mohan P; Yeggoni DP; Babu ZR; Kumar PB; Rao AD; Subramanyam R; Damu AG
    Mol Pharm; 2018 Jun; 15(6):2206-2223. PubMed ID: 29745222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cinnamoyl-N-Acylhydrazone-Donepezil Hybrids: Synthesis and Evaluation of Novel Multifunctional Ligands Against Neurodegenerative Diseases.
    Ortiz CJC; Damasio CM; Pruccoli L; Nadur NF; de Azevedo LL; Guedes IA; Dardenne LE; Kümmerle AE; Tarozzi A; Viegas C
    Neurochem Res; 2020 Dec; 45(12):3003-3020. PubMed ID: 33079324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of oxidative stress and other pathologies in Alzheimer's disease.
    Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
    Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxypyridinone-benzofuran hybrids with potential protective roles for Alzheimer´s disease therapy.
    Hiremathad A; Chand K; Tolayan L; Rajeshwari ; Keri RS; Esteves AR; Cardoso SM; Chaves S; Santos MA
    J Inorg Biochem; 2018 Feb; 179():82-96. PubMed ID: 29182921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ellagic acid: Insights into its neuroprotective and cognitive enhancement effects in sporadic Alzheimer's disease.
    Jha AB; Panchal SS; Shah A
    Pharmacol Biochem Behav; 2018 Dec; 175():33-46. PubMed ID: 30171934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.